Chapter 1 - General Provisions and Definitions

California Health and Safety Code — §§ 11000-11033

Showing inline text for up to 20 sections. Open a section link to read its full text.

Sections (37)

Repealed and added by Stats. 1972, Ch. 1407.

This division shall be known as the “California Uniform Controlled Substances Act.”

Repealed and added by Stats. 1972, Ch. 1407.

Unless the context otherwise requires, the definitions in this chapter govern the construction of this division.

Repealed and added by Stats. 1972, Ch. 1407.

“Administer” means the direct application of a controlled substance, whether by injection, inhalation, ingestion, or any other means, to the body of a patient for his immediate needs or to the body of a research subject by any of the following:

(a)A practitioner or, in his presence, by his authorized agent.
(b)The patient or research subject at the direction and in the presence of the practitioner.

Repealed and added by Stats. 1972, Ch. 1407.

“Agent” means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser. It does not include a common or contract carrier, public warehouseman, or employee of the carrier or warehouseman.

Repealed and added by Stats. 1972, Ch. 1407.

“Attorney General” means the Attorney General of the State of California.

Repealed and added by Stats. 1972, Ch. 1407.

“Board of Pharmacy” means the California State Board of Pharmacy.

Amended by Stats. 2025, Ch. 248, Sec. 23. (AB 8) Effective January 1, 2026.

(a)Before January 1, 2026, “concentrated cannabis” means the separated resin, whether crude or purified, obtained from cannabis.
(b)Beginning on January 1, 2026, and until January 1, 2028, “concentrated cannabis” or “cannabis concentrate” means cannabis that has undergone a process to concentrate one or more active cannabinoids, thereby increasing potency, and includes extracts, oils, hash, dab, shatter, rosin, wax, and the separated resin, whether crude or purified.
(c)Beginning on January 1, 2028, the following apply:
(1)“Concentrated cannabis” or

“cannabis concentrate” means cannabis or industrial hemp that has undergone a process to concentrate one or more active cannabinoids, thereby increasing potency, and includes extracts, oils, hash, dab, shatter, rosin, wax, and the separated resin, whether crude or purified.

(2)“Cannabis concentrate” does not include CBD isolate, as defined in Section 26001 of the Business and Professions Code.

Repealed and added by Stats. 1972, Ch. 1407.

“Customs broker” means a person in this state who is authorized to act as a broker for any of the following:

(a)A person in this state who is licensed to sell, distribute, or otherwise possess any controlled substance.
(b)A person in any other state who ships any controlled substance into this state.
(c)A person in this state or any other state who ships or transfers any controlled substance through this state.

Added by Stats. 1972, Ch. 1407.

“Deliver” or “delivery” means the actual, constructive, or attempted transfer from one person to another of a controlled substance, whether or not there is an agency relationship.

Repealed and added by Stats. 1972, Ch. 1407.

“Dispense” means to deliver a controlled substance to an ultimate user or research subject by or pursuant to the lawful order of a practitioner, including the prescribing, furnishing, packaging, labeling, or compounding necessary to prepare the substance for that delivery.

Repealed and added by Stats. 1972, Ch. 1407.

“Dispenser” means a practitioner who dispenses.

Repealed and added by Stats. 1972, Ch. 1407.

“Distribute” means to deliver other than by administering or dispensing a controlled substance.

Repealed and added by Stats. 1972, Ch. 1407.

“Distributor” means a person who distributes. The term distributor also includes warehousemen handling or storing controlled substances and customs brokers.

Repealed and added by Stats. 1972, Ch. 1407.

“Drug” means (a) substances recognized as drugs in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them; (b) substances intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or animals; (c) substances (other than food) intended to affect the structure or any function of the body of man or animals; and (d) substances intended for use as a component of any article specified in subdivision (a), (b), or (c) of this section. It does not include devices or their components, parts, or accessories.

Amended by Stats. 2024, Ch. 701, Sec. 1. (AB 2136) Effective January 1, 2025.

(a)“Drug paraphernalia” means all equipment, products, and materials of any kind that are designed for use or marketed for use, in planting, propagating, cultivating, growing, harvesting, manufacturing, compounding, converting, producing, processing, preparing, packaging, repackaging, storing, containing, concealing, injecting, ingesting, inhaling, or otherwise introducing into the human body a controlled substance in violation of this division. It includes, but is not limited to:
(1)Kits designed for use or marketed for use in planting, propagating, cultivating, growing, or harvesting of any species of plant that is a controlled substance or from which a controlled substance can be

derived.

(2)Kits designed for use or marketed for use in manufacturing, compounding, converting, producing, processing, or preparing controlled substances.
(3)Isomerization devices designed for use or marketed for use in increasing the potency of any species of plant that is a controlled substance.
(4)Scales and balances designed for use or marketed for use in weighing or measuring controlled substances.
(5)Containers and other objects designed for use or marketed for use in storing or concealing controlled substances.
(6)Hypodermic syringes, needles, and other objects designed for use or

marketed for use in parenterally injecting controlled substances into the human body.

(7)Objects designed for use or marketed for use in ingesting, inhaling, or otherwise introducing cannabis, cocaine, hashish, or hashish oil into the human body, such as:
(A)Carburetion tubes and devices.
(B)Smoking and carburetion masks.
(C)Roach clips, meaning objects used to hold burning material, such as a cannabis cigarette, that has become too small or too short to be held in the hand.
(D)Miniature cocaine spoons, and cocaine vials.
(E)Chamber

pipes.

(F)Carburetor pipes.
(G)Electric pipes.
(H)Air-driven pipes.
(I)Chillums.
(J)Bongs.
(K)Ice pipes or chillers.
(8)Testing equipment designed for use or marketed for use in identifying, or in analyzing the strength, effectiveness, or purity of, controlled substances, except as otherwise provided in subdivision (d).
(b)For the purposes of this section, the phrase “marketed for use” means

advertising, distributing, offering for sale, displaying for sale, or selling in a manner that promotes the use of equipment, products, or materials with controlled substances.

(c)In determining whether an object is drug paraphernalia, a court or other authority may consider, in addition to all other logically relevant factors, the following:
(1)Statements by an owner or by anyone in control of the object concerning its use.
(2)Instructions, oral or written, provided with the object concerning its use for ingesting, inhaling, or otherwise introducing a controlled substance into the human body.
(3)Descriptive materials accompanying the object that explain or

depict its use.

(4)National and local advertising concerning its use.
(5)The manner in which the object is displayed for sale.
(6)Whether the owner or anyone in control of the object is a legitimate supplier of like or related items to the community, such as a licensed distributor or dealer of tobacco products.
(7)Expert testimony concerning its use.
(d)Notwithstanding paragraph (8) of subdivision (a), “drug paraphernalia” does not include any testing equipment designed, marketed, intended to be used, or used, to test a substance for the presence of contaminants, toxic substances, hazardous compounds, or

other adulterants, or controlled substances that include, without limitation, fentanyl, ketamine, gamma hydroxybutyric acid, or any analog of fentanyl.

(e)If any provision of this section or the application thereof to any person or circumstance is held invalid, it is the intent of the Legislature that the invalidity shall not affect other provisions or applications of the section that can be given effect without the invalid provision or application and to this end the provisions of this section are severable.

Amended by Stats. 1992, Ch. 978, Sec. 2. Effective January 1, 1993.

“Federal bureau” means the Drug Enforcement Administration of the United States Department of Justice, or its successor agency.

Repealed and added by Stats. 1972, Ch. 1407.

“Furnish” has the same meaning as provided in Section 4048.5 of the Business and Professions Code.

Added by Stats. 1972, Ch. 1407.

“Manufacturer” has the same meaning as provided in Section 4034 of the Business and Professions Code.

Amended by Stats. 2025, Ch. 248, Sec. 24. (AB 8) Effective January 1, 2026. Note: This section was amended on Nov. 8, 2016, by initiative Prop. 64.

“Cannabis” means all parts of the plant Cannabis sativa Linnaeus, Cannabis indica, or Cannabis ruderalis, whether growing or not; the seeds thereof; the resin from glandular trichomes or extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin. It does not include either of the following:

(a)Industrial hemp, as defined in Section 11018.5.
(b)The weight of any other ingredient combined with cannabis to prepare topical or oral administrations, food, drink, or other product.

Amended by Stats. 2025, Ch. 248, Sec. 25. (AB 8) Effective January 1, 2026. Note: This section was added on Nov. 8, 2016, by initiative Prop. 64.

(a)“Cannabis products” means a product containing cannabis or cannabis concentrate and includes, but is not limited to, edible, topical, and inhaled products, and products intended for use on, or consumption by, an animal.
(b)It shall be presumed that a product intended for human or animal consumption that contains or purports to contain any tetrahydrocannabinol is a cannabis product, regardless of the nature or source of the cannabinoids. This presumption may be rebutted by evidence showing that the product complies with Chapter 9 (commencing with Section 111920) of Part 5 of Division 104 and any regulations promulgated pursuant to that

chapter.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.

Open the section link to read its full text.